Control of gene expression in plants

Details for Australian Patent Application No. 2002251724 (hide)

Owner Syngenta Participations AG

Inventors Brown, Jeffrey, Andrew; Cockrell, Adam, Scott; Valentine, Scott, Arthur; Johnson, Brian, David; Pascal, Erica, Judith

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002251724

PCT Pub. Number WO2002/061102

Priority 60/242,969 24.10.00 US

Filing date 24 October 2001

Wipo publication date 12 August 2002

Acceptance publication date 21 June 2007

International Classifications

A01H 5/00 (2006.01) Products

C07K 14/72 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002251724

7 April 2005 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Brown, Jeffrey Andrew

21 June 2007 Application Accepted

  Published as AU-B-2002251724

18 October 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002251725-COMPOSITIONS AND METHODS FOR BIOMEDICAL APPLICATIONS

2002251723-Gene delivery formulations and methods for treatment of ischemic conditions